摘要 |
The present invention relates to an antibody-linker-drug conjugate having an excellent anti-cancer activity, a preparation method thereof, and an anti-cancer agent composition containing the same as an active ingredient. In particular, in the antibody-linker-drug conjugate, the antibody and the cytotoxic drug are conjugated by the catalyst-decomposition type peptide linker, which can be directly bound to a lysine residue of the antibody. |
申请人 |
CELLTRION, INC. |
发明人 |
PARK, YOUNG JUN;JEONG, JIN KYO;CHOI, YOUNG MI;LEE, MIN SEOB;CHOI, JOON HUN;LEE, JIN SEO;CHO, EUN JOO;SONG, HYUN NAM;PARK, SUNG JUN;LEE, JONG HYOUP;LEE, SANG YUP;LEE, IN SUK;KIM, JOON WOO;HONG, SEUNG SUH;KIM, YEON JUNG;KIM, KYOUNG SUK |